Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2017 Annual Report Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.13
Change (%) - 0.05 (4.24%)
Volume789,209
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.13 with a 52 week high of $3.19 and a 52 week low of $0.91.
Recent Investor News
04/16/18
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
04/12/18
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™
Investor Events
There are currently no events scheduled.
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet